Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations . Rev Diabet Stud. 2023;6(2). Accessed September 13, 2025. https://diabeticstudies.org/index.php/RDS/article/view/259